The approval extends the medication to a younger pediatric population, marking the first FDA-approved treatment for children with this immunodeficiency.
News|Articles|March 22, 2004
New Product Newswire
New Product Newswire for March 22, 2004
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
GLP-1 Prescribing Rose Among Adults With Serious Mental Illness
3
AI, Automation Are Transforming Pharmacies into Proactive Care Hubs
4
Expert Discusses Flu and COVID-19 Vaccine Guidance
5